Co‐pathologies and biological processes beyond amyloid‐beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies
Journal of Internal Medicine · 2026
DOI: 10.1111/joim.70096 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Daniel Ferreira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockho…. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Center for Innovative Medicine, ALF Medicine.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is neuropathologically defined by amyloid‐beta (Aβ) plaques and tau neurofibrillary tangles. However, co‐pathologies and other pathobiological processes are involved in the pathogenesis of AD, contributing to neurodegeneration and clinical symptoms. The most common co‐pathologies in people with AD are alpha‐synucleinopathy, vascular brain injury and transactive response DNA‐binding protein of 43 kDa‐related pathology. Neuroinflammation, iron accumulation, cholinergic dysfunction and cellular senescence are recognized pathobiological processes beyond Aβ‐ and tau‐related pathology. However, the exact mechanisms by which these co‐pathologies and pathobiological processes contribute to the neurodegeneration and clinical symptoms in people with AD remain unclear. The individual combination of these co‐pathologies and pathobiological processes increases phenotypical heterogeneity in people with AD. This highlights the unmet need to advance their current understanding, and the field strives to develop accurate biomarkers for personalized assessment and investigation. Elucidating this biologic‐clinical complexity and heterogeneity is crucial for increasing our current understanding of AD, with implications for diagnosis, prognosis and therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
- Facultad de Ciencias de la Salud, Las Palmas, Universidad Fernando Pessoa Canarias, Santa María de Guía, España.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida, USA.
- Department of Neurology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland.
- Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden.
ORCID-Profile: Anna Marseglia, Patrizia Mecocci
Förderung
- Vetenskapsrådet
- Center for Innovative Medicine
- ALF Medicine
- Swedish Brain Foundation
- Hjärnfonden
- Alzheimerfonden
- Gun och Bertil Stohnes Foundation
- Åke Wiberg Foundation
Zitieren
APA
Ferreira, D., Chmiela, T., Eriksdotter, M., Jack, C. R., Kalpouzos, G., Marseglia, A., Mecocci, P., Nordberg, A., Religa, D., & Westman, E. (2026). Co‐pathologies and biological processes beyond amyloid‐beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies. Journal of Internal Medicine. https://doi.org/10.1111/joim.70096
Vancouver
Ferreira D, Chmiela T, Eriksdotter M, Jack CR, Kalpouzos G, Marseglia A, et al. Co‐pathologies and biological processes beyond amyloid‐beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies. Journal of Internal Medicine. 2026. doi:10.1111/joim.70096
BibTeX
@article{Ferreira2026,
author = {Ferreira, Daniel and Chmiela, Tomasz and Eriksdotter, Maria and Jack, Clifford R and Kalpouzos, Grégoria and Marseglia, Anna and Mecocci, Patrizia and Nordberg, Agneta and Religa, Dorota and Westman, Eric},
title = {Co‐pathologies and biological processes beyond amyloid‐beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies},
journal = {Journal of Internal Medicine},
year = {2026},
doi = {10.1111/joim.70096}
}
EUVIMED